Related Experiment Video
Updated: Jun 20, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Topical chlormethine hydrochloride causing bullous reaction.
Ka Yan Ngai1, Ho Yin Chan, Fu Ng
1Caritas Medical Centre, Hong Kong, SAR, China. a9820898@graduate.hku.hk
Clinical Toxicology (Philadelphia, Pa.)
|September 26, 2009
Summary
Topical chlormethine hydrochloride misuse for vitiligo caused severe skin reactions. Management involves decontamination and monitoring for complications from this overdose.
Area of Science:
- Dermatology
- Toxicology
Background:
- Vitiligo is a condition causing skin depigmentation.
- Chlormethine hydrochloride is a chemotherapy agent sometimes used off-label for dermatological conditions.
Observation:
- A case of a woman misusing chlormethine hydrochloride lotion for vitiligo is presented.
- The misuse led to significant dermatological complications, including urticarial and bullous reactions.
Findings:
- Topical chlormethine hydrochloride overdose can result in severe local skin reactions.
- Effective management strategies include immediate surface decontamination and vigilant follow-up for potential adverse effects.
Implications:
- Highlights the risks associated with non-prescribed use of potent topical agents.
- Emphasizes the importance of proper patient education and monitoring in dermatological treatments.
- Informs clinical practice regarding the management of topical chemotherapy overdoses.
Related Concept Videos
01:11Reactions at the Benzylic Position: Halogenation
Benzylic halogenation takes place under conditions that favor radical reactions such as heat, light, or a free radical initiator like peroxide.
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...